Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failure

Abstract The Platelet-to-Lymphocyte Ratio (PLR) has emerged as a cost-effective biomarker for systemic inflammation and adverse cardiovascular outcomes, yet its prognostic value in critically ill patients with heart failure (HF) remains unclear. Leveraging the MIMIC-IV database, this study investiga...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinyu Hu, Shijiao Cheng, Huaan Du, Yuehui Yin
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-83583-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559416160124928
author Xinyu Hu
Shijiao Cheng
Huaan Du
Yuehui Yin
author_facet Xinyu Hu
Shijiao Cheng
Huaan Du
Yuehui Yin
author_sort Xinyu Hu
collection DOAJ
description Abstract The Platelet-to-Lymphocyte Ratio (PLR) has emerged as a cost-effective biomarker for systemic inflammation and adverse cardiovascular outcomes, yet its prognostic value in critically ill patients with heart failure (HF) remains unclear. Leveraging the MIMIC-IV database, this study investigates the association between PLR and 1-year all-cause mortality in 7,217 ICU patients with HF. Patients were stratified into tertiles (0–126.45, 126.45–252.40, and 252.40–1000), and mortality risk was analyzed using Kaplan-Meier survival curves and Cox proportional hazards models. Elevated PLR was independently associated with higher mortality, with the highest tertile showing a 36% increased risk compared to the lowest (HR 1.36, 95% CI: 1.23–1.50, P < 0.001). Each tertile increment corresponded to a 17% rise in risk. Subgroup analyses revealed stronger associations in hypertensive patients and identified renal dysfunction and red cell distribution width as key modifiers. Integrating PLR with SOFA and APS III scores significantly enhanced predictive accuracy. By reflecting systemic inflammation and immune dysregulation, PLR offers a robust tool for long-term risk stratification and personalized management of ICU patients with HF. These findings highlight the potential of PLR to refine prognostic models, guide clinical decision-making, and improve critical care outcomes.
format Article
id doaj-art-26c417787d4848edb63f1a7ba8e9836a
institution Kabale University
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-26c417787d4848edb63f1a7ba8e9836a2025-01-05T12:27:48ZengNature PortfolioScientific Reports2045-23222024-12-011411910.1038/s41598-024-83583-1Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failureXinyu Hu0Shijiao Cheng1Huaan Du2Yuehui Yin3Department of Cardiovascular Medicine, The Second Affiliated Hospital of Chongqing Medical UniversityDepartment of Medical Affairs, Chongqing University Fuling HospitalDepartment of Cardiovascular Medicine, University-Town Hospital of Chongqing Medical UniversityDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Chongqing Medical UniversityAbstract The Platelet-to-Lymphocyte Ratio (PLR) has emerged as a cost-effective biomarker for systemic inflammation and adverse cardiovascular outcomes, yet its prognostic value in critically ill patients with heart failure (HF) remains unclear. Leveraging the MIMIC-IV database, this study investigates the association between PLR and 1-year all-cause mortality in 7,217 ICU patients with HF. Patients were stratified into tertiles (0–126.45, 126.45–252.40, and 252.40–1000), and mortality risk was analyzed using Kaplan-Meier survival curves and Cox proportional hazards models. Elevated PLR was independently associated with higher mortality, with the highest tertile showing a 36% increased risk compared to the lowest (HR 1.36, 95% CI: 1.23–1.50, P < 0.001). Each tertile increment corresponded to a 17% rise in risk. Subgroup analyses revealed stronger associations in hypertensive patients and identified renal dysfunction and red cell distribution width as key modifiers. Integrating PLR with SOFA and APS III scores significantly enhanced predictive accuracy. By reflecting systemic inflammation and immune dysregulation, PLR offers a robust tool for long-term risk stratification and personalized management of ICU patients with HF. These findings highlight the potential of PLR to refine prognostic models, guide clinical decision-making, and improve critical care outcomes.https://doi.org/10.1038/s41598-024-83583-1PLRHeart failureAll-cause mortalityInflammationMIMIC-IV
spellingShingle Xinyu Hu
Shijiao Cheng
Huaan Du
Yuehui Yin
Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failure
Scientific Reports
PLR
Heart failure
All-cause mortality
Inflammation
MIMIC-IV
title Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failure
title_full Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failure
title_fullStr Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failure
title_full_unstemmed Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failure
title_short Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failure
title_sort association of platelet to lymphocyte ratio with 1 year all cause mortality in icu patients with heart failure
topic PLR
Heart failure
All-cause mortality
Inflammation
MIMIC-IV
url https://doi.org/10.1038/s41598-024-83583-1
work_keys_str_mv AT xinyuhu associationofplatelettolymphocyteratiowith1yearallcausemortalityinicupatientswithheartfailure
AT shijiaocheng associationofplatelettolymphocyteratiowith1yearallcausemortalityinicupatientswithheartfailure
AT huaandu associationofplatelettolymphocyteratiowith1yearallcausemortalityinicupatientswithheartfailure
AT yuehuiyin associationofplatelettolymphocyteratiowith1yearallcausemortalityinicupatientswithheartfailure